Evidence map›Paper›PMID 41164026›Full record

ArticleCureus2025

Delayed Diagnosis of Non-Bacterial Thrombotic Endocarditis in a Patient With Metastatic Lung Cancer.

Efe Opone, Reza Aghamohammadzadeh

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Efe OponeMedicine, University Hospitals Sussex, Hove, GBR.
Reza AghamohammadzadehCardiology, University Hospitals Sussex, Hove, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-bacterial thrombotic endocarditis (NBTE) is characterised by sterile vegetations on cardiac valves and is most frequently associated with malignancy or chronic inflammatory disorders. Diagnosis is challenging, as clinical signs typically manifest after embolic complications. We report the case of a 42-year-old man with a history of myocardial infarction and lacunar stroke earlier in the year, who presented with chronic cough, progressive dyspnoea, and fatigue. On admission, he was tachycardic and tachypneic, with a diastolic murmur and bibasal crackles. Laboratory tests revealed normocytic anaemia and thrombocytopenia. Computed tomography pulmonary angiogram (CTPA) excluded pulmonary embolism but demonstrated a large pericardial effusion, confirmed on transthoracic echocardiography, along with severe aortic regurgitation and a mobile echodensity on the aortic valve suspicious for vegetation. Pericardiocentesis drained 940 mL of haemoserous fluid, and cytology subsequently confirmed metastatic adenocarcinoma of probable pulmonary origin. Further imaging revealed bilateral renal and splenic infarcts. Serial blood cultures were negative. Given the combination of sterile vegetations, systemic embolisation, and advanced malignancy, a diagnosis of NBTE was made. The patient was managed supportively, with surgical intervention deferred in view of disseminated malignancy and poor prognosis. His condition deteriorated rapidly, and he died several days after discharge. This case illustrates the importance of considering NBTE in patients presenting with recurrent embolic events, particularly in the context of malignancy. Prompt recognition and initiation of anticoagulation may reduce the risk of further embolic complications, although prognosis remains poor in cancer-associated NBTE.

Indexed as

adenocarcinoma lungcancer-associated thrombosisembolic phenomenaendocarditislung cancernon-infective thrombotic endocarditispericardial effusion (pe)thromboembolism and splenic infarction

Identifiers

PMID41164026
PMCPMC12560192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.